Foresite Capital Management V, LLC Lyell Immunopharma, Inc. Transaction History
Foresite Capital Management V, LLC
- $12.5 Million
- Q1 2025
A detailed history of Foresite Capital Management V, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Foresite Capital Management V, LLC holds 8,133,047 shares of LYEL stock, worth $83 Million. This represents 35.24% of its overall portfolio holdings.
Number of Shares
8,133,047
Previous 8,133,047
-0.0%
Holding current value
$83 Million
Previous $5.21 Million
15.64%
% of portfolio
35.24%
Previous 14.48%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$206 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$163 Million9.84% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$154 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$154 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$138 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.53B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...